Stockscreener 앱 받기
28.43
0.25%
-0.07
시간 외 거래:
28.43
전일 마감가:
$28.50
열려 있는:
$28.45
하루 거래량:
386.84K
Relative Volume:
0.67
시가총액:
$1.35B
수익:
$723.55M
순이익/손실:
$157.72M
주가수익비율:
9.4767
EPS:
3
순현금흐름:
$170.15M
1주 성능:
+0.49%
1개월 성능:
-9.72%
6개월 성능:
-40.80%
1년 성능:
-35.25%
1일 변동 폭
$28.23
$28.71
1주일 범위
$27.80
$28.83
52주 변동 폭
$25.89
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
28.43 | 1.35B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
163.11 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.05 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.08 | 17.28B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.81 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Raymond James Financial Inc. Takes $3.45 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Quantbot Technologies LP Invests $945,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Investment Report - Stock Traders Daily
Fox Run Management L.L.C. Takes $688,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - ACCESS Newswire
Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth - StockTitan
Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat
Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Amundi - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World
Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 0.46% on Mar 19 - GuruFocus.com
US Bancorp DE Has $31,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
(AMPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
On Nasdaq, I Prefer The Less-Famous Stocks - Forbes
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowTime to Sell? - MarketBeat
Wealthfront Advisers LLC Acquires New Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Smartleaf Asset Management LLC Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks | FinancialContent - Financial Content
Amphastar stock hits 52-week low at $26.97 amid market challenges - Investing.com Australia
Amphastar at Barclays Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK
Amphastar stock hits 52-week low at $26.97 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 4,231 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
(AMPH) Proactive Strategies - Stock Traders Daily
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock - Investing.com India
Amphastar Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Amphastar Pharmaceuticals CFO sells $116,515 in stock By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals CFO sells $116,515 in stock - Investing.com
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.70%
0.05%
자본화:
|
볼륨(24시간):